07:00 , May 26, 2014 |  BioCentury  |  Emerging Company Profile

Annexin: Attenuating vascular inflammation

Annexin Pharmaceuticals AB is developing an annexin A5 protein to help stop disease progression and prevent limb amputation in peripheral arterial occlusive disease. The protein has therapeutic benefits including anti-inflammatory, antithrombotic and anti-atherosclerotic activity. Current...